Rwanda's medicines regulator. WHO announced in December 2024 that it had reached maturity level 3, a stable and well-functioning regulatory system.
The Rwanda Food and Drugs Authority regulates medicines and other health products in Rwanda. WHO announced on 5 December 2024 that it and Senegal's regulator had become the seventh and eighth in Africa to reach maturity level 3 in WHO's global benchmarking of national regulatory authorities, after an assessment finalised in October 2024; WHO quoted its Assistant Director-General for Access to Medicines saying Rwanda was the second country in the East African region to reach the level, after Tanzania in 2018. The National Cancer Control Plan 2025 to 2029 plans a streamlined regulatory framework for approving and conducting cancer clinical trials.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/